or Try an Advanced Search...

    Hematological Malignancies Stocks List

    Symbol Grade Name % Change
    TGTX B TG Therapeutics, Inc. 2.44
    SNDX C Syndax Pharmaceuticals, Inc. 0.00
    CNTA C Centessa Pharmaceuticals plc 4.40
    PSTX D Poseida Therapeutics, Inc. 5.38
    ADAP D Adaptimmune Therapeutics plc 0.84
    ABBV D AbbVie Inc. 1.44
    ALRN D Aileron Therapeutics, Inc. 0.00
    MRKR F Marker Therapeutics, Inc. 3.10
    CERO F CERo Therapeutics Holdings, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
    Related Stock Lists: Cancer Solid Tumors Biopharmaceutical Immunotherapy Lymphoma Medicine Cancer Immunotherapy Cancer Treatment Clinical Medicine Immune System Treatment Of Cancer Tumor Virotherapy Adoptive Cell Transfer Cell Therapy Lung Cancer Non Small Cell Lung Cancer Oncogenes Ovarian Cancer Peptides

    Related ETFs - A few ETFs which own one or more of the above listed Hematological Malignancies stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 9.87
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ C Global X Robotics & Artificial Intelligence Thematic ETF 8.97
    GRID A First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 8.3
    MEDX F Horizon Kinetics Medical ETF 7.88
    View all Hematological Malignancies ETFs...
    Compare ETFs
    Compare BOTZ to MEDX Compare HDLB to GRID Compare HDLB to MEDX

        Hematological Malignancies Stocks Recent News

        Date Stock Title
        May 3 PSTX Broker Revenue Forecasts For Poseida Therapeutics, Inc. (NASDAQ:PSTX) Are Surging Higher
        May 2 ABBV Top 25 Stocks in the S&P 500 by Index Weight Right Now
        May 2 TGTX TG Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 2 ALRN Aileron reports data from Cohort 1 of Phase Ib inhaled IPF treatment trial
        May 2 PSTX Xyphos and Poseida to develop allogeneic cell therapies for cancer
        May 2 TGTX TG Therapeutics Inc (TGTX) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue Growth ...
        May 2 ABBV The top pharmaceutical companies by R&D expenditure
        May 2 TGTX Q1 2024 TG Therapeutics Inc Earnings Call
        May 1 ABBV BeiGene, AbbVie patent spat to get trial from USPTO appeals board
        May 1 PSTX Poseida gains on cell therapy pact with Astellas
        May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
        May 1 ADAP Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
        May 1 TGTX TG Therapeutics jumps as Q1 Briumvi sales top guidance
        May 1 ALRN Aileron announces pricing of underwritten registered direct offering priced at-the-market under Nasdaq rules of up to about $40M
        May 1 PSTX Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
        May 1 ALRN Aileron Therapeutics announces positive data from its early stage pulmonary fibrosis treatment trial
        May 1 ALRN Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million
        May 1 TGTX TG Therapeutics Inc (TGTX) Surpasses Revenue Estimates in Q1 2024, Despite Widening Net Loss
        May 1 TGTX TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
        May 1 ALRN Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
        Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
        Related Stock Lists: Cancer Solid Tumors Biopharmaceutical Immunotherapy Lymphoma Medicine Cancer Immunotherapy Cancer Treatment Clinical Medicine Immune System Treatment Of Cancer Tumor Virotherapy Adoptive Cell Transfer Cell Therapy Lung Cancer Non Small Cell Lung Cancer Oncogenes Ovarian Cancer Peptides
        Hematological Malignancies

        Hematological malignancies are cancers of the blood, bone marrow, and lymphatic system. These cancers can affect the production and function of blood cells, leading to a variety of symptoms and complications. Common types of hematological malignancies include leukemia, lymphoma, and multiple myeloma. Treatment for these cancers may include chemotherapy, radiation therapy, and/or stem cell transplantation.

        Browse All Tags